Good evening :)
Add to Watchlist
Share

Tata India Pharma & Healthcare Fund(IDCW)

IDCW
35.600.26% (+0.09)

How to use scorecard? Learn more

Tata India Pharma & Healthcare Fund(IDCW)

IDCW
EquitySectoral Fund - Pharma & Health Care
Mid-size FundAssets Under Mgmt: ₹ 1,213 Cr
Very High RiskPrinciple investment will be at very high risk
35.600.26% (+0.09)

Price Chart

High
—
Low
—
Returns
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

How to use scorecard? Learn more

EquitySectoral Fund - Pharma & Health Care
Mid-size FundAssets Under Mgmt: ₹ 1,213 Cr
Very High RiskPrinciple investment will be at very high risk

Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
0.6948.632.44
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.4752.722.09

Scheme Info

PlanPlanLock inLock inExit LoadExit Load
IDCW0 yrs0.25%
0.25% on or before 30D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
NIFTY PHARMA - TRI

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care

Returns

Scheme

Ratios

Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
Tata India Pharma & Healthcare Fund(IDCW)42.07%23.72%15.16%
Nippon India Pharma Fund(IDCW)26.67%17.19%11.92%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(IDCW-Payout)36.72%16.21%16.75%
SBI Healthcare Opp Fund(IDCW-Payout)43.44%25.26%17.33%

Price Comparison

Compare Tata India Pharma & Healthcare Fund(IDCW) with any MF, ETF, stock or index
Compare Tata India Pharma & Healthcare Fund(IDCW) with any MF, ETF, stock or index
Tata India Pharma & Healthcare Fund(IDCW)
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Asset Allocation

Actual

Target

Mar 2024

Jun 2024

Sep 2024

Nov 2024

ACTUAL
Cash & EquivalentsEquity4.28%95.72%

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Distribution

+1 moreDiversified ChemicalsFertilizers & Agro ChemicalsOthersLabs & Life Sciences ServicesPharmaceuticals0.32 %0.40 %0.88 %6.85 %14.33 %77.21 %

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Tickertape Separator

Sector Weightage

Sep 23Dec 23Mar 24Jun 24Sep 24Nov 2481.16%80.68%78.22%78.98%76.07%77.21%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change
  • Sun Pharmaceutical Industries Ltd
    SUNPHARMA
    3M change : -0.58 %

    Holdings

    11.80 %

    -0.58 %
  • Aurobindo Pharma Ltd
    AUROPHARMA
    3M change : -2.12 %

    Holdings

    7.71 %

    -2.12 %
  • Lupin Ltd
    LUPIN
    3M change : -0.84 %

    Holdings

    6.93 %

    -0.84 %

AMC Profile

Established in 1994, Tata Asset Management Private Limited has a track record of more than 25 years in investment management. Tata Asset Management Private Limited manages investments of Tata Mutual Fund.

  • No.of Schemes

    60

  • Total AUM

    ₹ 1,86,091.18 Cr.

Fund Manager Profile

Meeta Shetty

AUM:  ₹25,879.79 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 12yrs

Rajat Srivastava

AUM:  ₹1,213.92 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 8yrs

Manager Performance (0)

Loading...

Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Opinions and Fund Reviews

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.
News Thumbnail

Outlook for the Pharma & Healthcare sector

3 years ago•Tata Mutual Fund

News Thumbnail

Tata India Pharma & Healthcare Fund Direct Growth Fund Review - Meeta Shetty | Mutual Fund Watch

4 years ago•Groww Mutual fund

News Thumbnail

8 Reasons to invest in Tata India Pharma & Healthcare Fund

4 years ago•Tata Mutual Fund

News Thumbnail

Meeta Shetty, Assistant Fund Manager's Views on Tata India Pharma & Healthcare Fund

4 years ago•Tata Mutual Fund